BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37565053)

  • 21. Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms.
    Neuwelt AJ; Kimball AK; Johnson AM; Arnold BW; Bullock BL; Kaspar RE; Kleczko EK; Kwak JW; Wu MH; Heasley LE; Doebele RC; Li HY; Nemenoff RA; Clambey ET
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32312906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP
    J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.
    Vlková V; Štěpánek I; Hrušková V; Šenigl F; Mayerová V; Šrámek M; Šímová J; Bieblová J; Indrová M; Hejhal T; Dérian N; Klatzmann D; Six A; Reiniš M
    Oncotarget; 2014 Aug; 5(16):6923-35. PubMed ID: 25071011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.
    Piskurich JF; Linhoff MW; Wang Y; Ting JP
    Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
    Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
    J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA; Chernichovski I; Lahat N
    Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.
    Londhe P; Zhu B; Abraham J; Keller C; Davie J
    Int J Cancer; 2012 Aug; 131(4):E437-48. PubMed ID: 21989738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
    Morris AC; Riley JL; Fleming WH; Boss JM
    Am J Reprod Immunol; 1998 Dec; 40(6):385-94. PubMed ID: 9894561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
    Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial distribution of histone methylation during MHC class II expression.
    Chou SD; Tomasi TB
    Mol Immunol; 2008 Feb; 45(4):971-80. PubMed ID: 17850872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
    Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
    J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of MHC class I expression by the MHC class II transactivator CIITA.
    Martin BK; Chin KC; Olsen JC; Skinner CA; Dey A; Ozato K; Ting JP
    Immunity; 1997 May; 6(5):591-600. PubMed ID: 9175837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
    O'Keefe GM; Nguyen VT; Benveniste EN
    Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.